Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: Results from the NSABP P1 and P2 clinical trials
Matthew P. Goetz
, Daniel J. Schaid
, D. Lawrence Wickerham
, Stephanie Safgren
, Taisei Mushiroda
, Michiaki Kubo
, Anthony Batzler
, Joseph P. Costantino
, Victor G. Vogel
, Soonmyung Paik
, Erin E. Carlson
, David A. Flockhart
, Norman Wolmark
, Yusuke Nakamura
, Richard M. Weinshilboum
, James N. Ingle
, Matthew M. Ames
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: Results from the NSABP P1 and P2 clinical trials'. Together they form a unique fingerprint.